Amy Scurlock
Pediatric Allergy/Immunology · Little Rock, ARNPI 1396835898
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $3,600 of the $3,763 with a category attached, or 95.7%. Aimmune Therapeutics, Inc. accounts for 98.5% of it on its own, with 1 other manufacturer making up the rest.
Across 3 payments — averaging $1254.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aimmune Therapeutics, Inc.$4K
- Alk-abello, Inc$55
Across 107 payments — averaging $5163.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Aimmune Therapeutics, Inc.$379K
- Novartis$174K
What the payments were for
- Speaking & faculty fees$3,60096%
- Food & beverage$1634%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aimmune Therapeutics, Inc. | 2 | $3,708 |
| Alk-abello, Inc | 1 | $55 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PALFORZIA$3,708
How this compares
Too few pediatric allergy/immunology providers in Arkansasto place this figure against a meaningful peer group, so we don't.
Other pediatric allergy/immunology in Little Rock
- Stacie JonesLittle Rock$41K
- Tamara PerryLittle Rock$176
- Dieu DoanLittle Rock$140
- Matthew BellRogers$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.